Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChesnara Regulatory News (CSN)

Share Price Information for Chesnara (CSN)

Share Price is delayed by 15 minutes
Get Live Data
317.50    0.50 (0.16%)
Bid:
315.50
Ask:
317.00
Spread: 1.50 (0.475%)
Market Cap: £732.37m
CSN Live PriceLast checked at - London Stock Exchange

Intraday Chesnara Share Chart

Interim Management Statement

19 Nov 2008 07:00

Chesnara plc

Interim Management Statement for the period from1 January 2008 to 17 November 2008

19 November 2008

This statement relates primarily to the financial position of Chesnara plc (the "Group") as at 30 September 2008 and to its financial performance during the first three quarters of the year. Where events and transactions have occurred since the end of the third quarter, which are estimated to have a material impact on management's core expectation of the financial position and/or financial performance of the Group, then these are identified together with a broad indication of their impact.

Embedded Value

The key determinant of Group performance in the calendar year to 30 September 2008 has continued to be the decline in global equity markets. The leading UK market indices show a 24% decline over that period, approximately half of which occurred since 30 June. The effect of the market fall over the first three quarters has been an ‚£8.2m net of tax reduction in European Embedded Value ("EEV"), of which ‚£3.2m occurred in the last quarter. Notwithstanding this the business has, in terms of fundamentals, performed ahead of expectations and this, together with the expected return from in-force business, has produced, at the end of the third quarter, a net of tax increase of some ‚£1.9m in the half-year reported EEV. Key contributors are:

* Continuing favourable lapse experience across both our key protection and endowment products, which led to a net of tax EEV increase of some ‚£4m in the first three quarters; * Endowment misselling complaints continue at relatively low levels with no significant change in uphold rates. Therefore the provision we hold continues to prove adequate; and * Expenses continue to be in line with management expectations.

After allowing for expenditure incurred in a share buyback operation before the quarter end the EEV movement may be summarised as:

‚£m As reported 30 June 2008 179.0 Third quarter earnings, net of tax 1.9 Reduction in equity, following share buyback operation (0.3) EEV at 30 September 2008 as adjusted for above items 180.6

Notwithstanding our continued conservative approach to the management of treasury funds we have one specific exposure in respect of a cash deposit of ‚£1.1m with Kaupthing Singer and Friedlander. Following their entry into administration this has been fully written down and is reflected in the above result.

Subsequent to this the Interim Dividend of ‚£5.8m has been paid and a further ‚£2.3m has been expended on the repurchase of shares. Taking these into account reduces the embedded value to ‚£172.5m.

Further investment market falls subsequent to the third quarter end (to 17 November) give rise to an estimated further net of tax reduction in EEV of some ‚£3.5m.

IFRS Result

The IFRS result has progressed from ‚£10.0m (‚£8.1m net of tax) at the half-year position to ‚£13.4m (‚£10.8m net of tax) at the cumulative three quarters' position.

This result takes account of the investment market conditions and investment writedown set out above, while the impact of favourable policy lapse experience, although overall beneficial to EEV, has an adverse short-term impact, insofar as statutory reserve releases in the life company are not as high as anticipated.

Financial Strength

The underlying emergence of surplus in the life company, and hence the capacity of the Group to continue to pursue its dividend policy, remains strong. This is reflected in the ratio of regulatory capital resources to regulatory capital requirements in the life company, which has improved from 227% at the 2008 half-year position to 237% at the end of the third quarter. The corresponding Group solvency (IGD) measure has improved from 348% at the half-year position to 359% at the end of the third quarter.

Whilst investment market performance has negatively affected the results to date and we, clearly, continue to be exposed to the impact of investment market performance on our policyholders' unit-linked funds, we believe that our wider exposure to adverse investment market performance is limited. We continue to maintain a prudent approach to policyholder non-linked and shareholder fund investments and have no exposure to asset-backed securities. We closely monitor counterparty exposure limits and apply minimum credit security ratings to all investments. Shareholder funds are held in cash deposits and fixed interest securities only. Furthermore, our long-established conservative approach to the estimation of the illiquidity yield premium means that the recent widening of bond yield spreads has had little impact on our results.

Share Buyback

Although the EEV has demonstrated a degree of resilience in the face of turbulence in investment markets, the Group's shares have traded at prices which represent a substantial discount to EEV over the last few months. Accordingly, in order to maximise shareholder value, we have taken the opportunity to undertake a share buyback operation. Commencing on 24 September 2008, this operation has, to date, given rise to the buyback of 2,390,194 shares at an average price of 108.4p per share. The closing price of 110p per share on 17 November 2008 represents a 34% discount to an estimated EEV of 167p per share on that date.

Market Opportunity

We believe that attractively priced assets are starting to become available as a result of the current turbulence in the market. We will continue to examine such opportunities as they arise and believe that we have a strong financial platform from which to pursue them, although, given the current climate, we will continue to apply strict financial and risk criteria to any prospective acquisitions.

EnquiriesGraham Kettleborough

Chief Executive, Chesnara Plc 07799 407519

Michael Henman

Cubitt Consulting 0207 367 5100

Notes to editors:

Chesnara plc, which listed on the London Stock Exchange in May 2004, is the owner of Countrywide Assured plc ("CA"). CA is a life assurance subsidiary that is substantially closed to new business. In June 2005 Chesnara acquired City of Westminster Assurance ("CWA") for ‚£47.8m. With effect from 30 June 2006, CWA's policies and assets were transferred into CA plc. Chesnara's operating model is to maintain a relatively small governance team and outsource the majority of its back office functions. Chesnara continues to seek acquisition opportunities in the financial services sector.

vendor
Date   Source Headline
10th Aug 201511:22 amRNSNotice of Results
20th May 20157:00 amRNSAcquisition
15th May 201511:56 amRNSResult of AGM
11th May 20154:17 pmRNSRegulatory Approval
28th Apr 20153:40 pmRNSDirector/PDMR Shareholding
27th Apr 20159:51 amRNSAnnual Financial Report
15th Apr 20157:00 amRNSAnnual Report and Accounts and Notice of AGM
31st Mar 20157:00 amRNSFinal Results
9th Mar 20158:48 amRNSNotice of Results
25th Feb 20159:29 amRNSHolding(s) in Company
21st Jan 20154:01 pmRNSDirector/PDMR Shareholding
5th Dec 20147:00 amRNSRegulatory Approval
4th Dec 201412:30 pmRNSPart VII Transfer Approval
3rd Dec 201412:58 pmRNSResults of Placing
3rd Dec 20147:01 amRNSProposed Acquisition and Placing
3rd Dec 20147:00 amRNSDirectorate Change
19th Nov 20147:00 amRNSInterim Management Statement
7th Nov 201412:54 pmRNSTotal Voting Rights
4th Nov 201410:18 amRNSDirector/PDMR Shareholdings / Total Voting Rights
9th Sep 20142:39 pmRNSHolding(s) in Company
29th Aug 20147:00 amRNSHalf Yearly Report
11th Aug 20144:01 pmRNSNotice of Results
21st Jul 201411:42 amRNSTotal Voting Rights
7th Jul 20141:41 pmRNSContract with HCL
19th Jun 20142:06 pmRNSDirectorate Change
20th May 20142:43 pmRNSDirector/PDMR Shareholding
19th May 20147:00 amRNS1st Quarter Results
16th May 201411:40 amRNSResult of AGM
28th Apr 201411:42 amRNSAnnual Financial Report
14th Apr 201412:26 pmRNSAnnual Report and Accounts and Notice of AGM
28th Mar 20141:28 pmRNSDirector/PDMR Shareholding
28th Mar 20147:01 amRNSFinal Results
10th Mar 201412:00 pmRNSNotice of Results
3rd Feb 201411:41 amRNSHolding(s) in Company
21st Jan 20141:56 pmRNSHolding(s) in Company
16th Jan 201410:27 amRNSHolding(s) in Company
28th Nov 20132:00 pmRNSAcquisition
19th Nov 20137:00 amRNS3rd Quarter Interim Management Statement
7th Nov 201311:55 amRNSResult of Meeting
22nd Oct 20135:30 pmRNSStatement re: Posting Circular to Shareholders
8th Oct 20137:00 amRNSSale of Direct Line Life & proposed capital return
8th Oct 20137:00 amRNSAcquisition
30th Aug 20137:00 amRNSHalf Yearly Report
12th Aug 20139:42 amRNSNotice of Results
31st Jul 20139:15 amRNSTotal Voting Rights
4th Jul 201310:10 amRNSListing Rule 9.6.14
28th Jun 20139:01 amRNSTotal Voting Rights
11th Jun 20138:30 amRNSDirectorate Change
22nd May 20133:59 pmRNSHolding(s) in Company
17th May 201311:37 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.